ARC — ARCpoint Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ARCpoint Inc. is a franchise system engaged in providing drug testing, alcohol screening, deoxyribonucleic acid (DNA) and clinical lab testing, corporate wellness programs, and employment and background screening, among other services. The Company sells franchises to individuals throughout the United States and provides support in the form of marketing, technology and training to new franchisees. The Company is a franchisor of ARCpoint Labs and supports over 120 independently owned locations. It develops corporate-owned labs committed to providing solutions for customers, businesses and physicians. It is also engaged in building a technology platform and a physician network to equip all ARCpoint labs with tools and solutions to serve their customers. The platform also digitalizes and streamlines administrative functions, such as materials purchasing, compliance, billing and physician services for ARCpoint franchise labs and other clients.
Directors
- Last Annual
- Last Interim
- Incorporated
- January 1st, 1970
- Public Since
- January 1st, 1970
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 61,947,000
- Address
- 101 North Main St., Suite 301, GREENVILLE, 29601
- Web
- Phone
- Auditors
Upcoming Events for ARC
Similar to ARC
Armada Data
TSX Venture Exchange
Avante Logixx
TSX Venture Exchange
Biorem
TSX Venture Exchange
BluMetric Environmental
TSX Venture Exchange
CHAR Technologies
TSX Venture Exchange
FAQ
As of Today at 06:01 UTC, shares in ARCpoint are trading at CA$0.18. This share price information is delayed by 15 minutes.
Shares in ARCpoint last closed at CA$0.18 and the price had moved by -22.01% over the past 365 days. In terms of relative price strength the ARCpoint share price has underperformed the Toronto Stock Exchange 300 Composite Index by -21.9% over the past year.
There is no consensus recommendation for this security.
ARCpoint does not currently pay a dividend.
ARCpoint does not currently pay a dividend.
ARCpoint does not currently pay a dividend.
To buy shares in ARCpoint you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.18, shares in ARCpoint had a market capitalisation of CA$10.84m.
Here are the trading details for ARCpoint:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: ARC
Based on an overall assessment of its quality, value and momentum ARCpoint is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ARCpoint. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -26.56%.
As of the last closing price of CA$0.18, shares in ARCpoint were trading -35.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ARCpoint PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on ARCpoint's directors